Empresas Lipigas (LIPIGAS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Oct, 2026Executive summary
Q1 2025 consolidated EBITDA reached CLP 33,390 MM, up 14.6% YoY; net income was CLP 12,350 MM, up 30.7%.
Gas sales volume increased 3.6% YoY to 199,635 equivalent tonnes, with higher LPG volumes in Chile and Colombia and natural gas volumes in Chile and Peru.
LTM EBITDA was CLP 159,559 MM, up 17.5% YoY; LTM equivalent sales volume totaled 900k tonnes, up 0.8%.
Financial highlights
Revenue rose 13.1% to CLP 209,138 MM; gross profit increased 8.6% to CLP 63,168 MM, and operating income rose 20.3% to CLP 19,429 MM.
Profit attributable to controlling owners was CLP 12,075 MM, up 29.8%; depreciation and amortization totaled CLP 13,961 MM, up 7.6%.
LTM operating income was CLP 105,017 MM, up 23.7%; LTM net income was CLP 65,951 MM, up 40.9%.
The non-operating result improved CLP 553 MM YoY to a loss of CLP 1,699 MM, reflecting guarantee-liability gains, non-operating sales, FX and equity-accounted gains, partly offset by lower interest income.
Outlook and guidance
2030 ambitions include leading Latin America in biogas commercialization, making Chilean plant operations carbon neutral, generating 25% of EBITDA outside Chile and 10% from businesses beyond gas.
Ñuble’s first Latin American BioLNG plant was 70% complete, with planned processing capacity of 7,500 m³ of biogas per day; BioLNG commercialization was expected to begin in 2025.
New LNG service stations in Chile and Peru and Chile’s first BioLNG production project were planned for launch in H2 2025.
Latest events from Empresas Lipigas
- EBITDA rose 3.5% as margins offset lower volumes, while net income fell 53.8%.LIPIGAS
Q1 2023 - 1H EBITDA rose 5.5% despite lower revenue, volumes and after-tax profit.LIPIGAS
Q2 2023 - 9M EBITDA rose 6.4% on stronger margins, despite lower volumes and earnings pressure.LIPIGAS
Q3 2023 - FY2023 EBITDA rose 13.6%, while lower revenue and non-operating costs weighed on earnings.LIPIGAS
Q4 2023 - Q1 EBITDA rose 55.8% to M$29,131 on stronger margins across all three markets.LIPIGAS
Q1 2024 - H1 EBITDA rose 37.2%, with gains across all three markets and 22.1% generated abroad.LIPIGAS
Q2 2024 - 9M EBITDA rose 29.5% to M$121,777, with growth across all three markets.LIPIGAS
Q3 2024 - FY24 EBITDA rose 23.9% as earnings grew across Chile, Colombia and Peru.LIPIGAS
Q4 2024 - H1 EBITDA rose 12.1% and net income 24.6%, alongside expansion into Ecuador.LIPIGAS
Q2 2025